NCT04321499View on ClinicalTrials.gov

SHOX2_PTGER4 DNA Methlyation in Lung Cancer

CompletedOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions
Lungcancer
Interventions
GENETIC

lung cancer

PCR for SHOX2 and PTGER4

Trial Locations (1)

45239

Ruhrlandklinik, Department of Interventional Pneumology, Essen

All Listed Sponsors
lead

University Hospital, Essen

OTHER

NCT04321499 - SHOX2_PTGER4 DNA Methlyation in Lung Cancer | Biotech Hunter | Biotech Hunter